Aclarion (ACON)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.02 (-13.60%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Aclarion (ACON)
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Key Insights

Critical company metrics and information

  • Share Price

    $0.14

  • Market Cap

    $1.44 Million

  • Total Outstanding Shares

    10.44 Million Shares

  • Total Employees

    6

  • Dividend

    No dividend

  • IPO Date

    April 22, 2022

  • SIC Description

    Services-medical Laboratories

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Phone Number

    833 275 2266

  • Address

    8181 arista place, Broomfield, CO, 80021

  • Homepage

    https://www.aclarion.com

Historical Stock Splits

If you bought 1 share of ACON before January 4, 2024, you'd have 0.06 shares today.
Execution DateSplit Amount
January 4, 20241-for-16 (Reverse Split)

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$-1.06 Million
Net Cash Flow, Continuing$139,410.00
Net Cash Flow From Financing Activities$1.30 Million
Net Cash Flow$139,410.00
Net Cash Flow From Financing Activities, Continuing$1.30 Million
Net Cash Flow From Investing Activities$-103,697.00

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Benefits Costs and Expenses$1.38 Million
Income Tax Expense/Benefit$0.00
Net Income/Loss$-1.38 Million
Gross Profit$-6,925.00
Preferred Stock Dividends And Other Adjustments$12,142.00
Diluted Earnings Per Share$-0.15

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Noncurrent Liabilities$0.00
Liabilities$678,267.00
Equity$2.51 Million
Assets$3.19 Million
Current Assets$1.90 Million
Liabilities And Equity$3.19 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2025 Financhle. All Rights Reserved.